Reich & Binstock
Free Initial Consultation Call
713-352-7883
713-352-7883

Pharmaceutical Liability Archives

New development in fluoroquinolone antibiotics cases

There has been a procedural development in lawsuits filed against the makers of fluoroquinolone drugs, which are linked to serious nerve damage. A group of judges known as the U.S. Judicial Panel on Multidistrict Litigation centralized all of the federal litigation of this nature before a single judge Aug. 17. The judge is based at a federal trial court in Minnesota.

Federal court's drug marketing ruling a Risperdal reminder

An Aug. 7 ruling by a federal district court in New York raised the issue of whether a drug company is culpable of "misbranding" a drug, in violation of federal regulations, when the company markets the drug for a purpose unapproved by the U.S. Food and Drug Administration. The case did not address in any way U.S. Justice Department and FDA proceedings in regard to the antipsychotic Risperdal, but it did address the broader issue of how far a drug company can go in the so-called "off-label" marketing of its product.

Federal court's drug marketing ruling a Risperdal reminder

An Aug. 7 ruling by a federal district court in New York raised the issue of whether a drug company is culpable of "misbranding" a drug, in violation of federal regulations, when the company markets the drug for a purpose unapproved by the U.S. Food and Drug Administration. The case did not address in any way U.S. Justice Department and FDA proceedings in regard to the antipsychotic Risperdal, but it did address the broader issue of how far a drug company can go in the so-called "off-label" marketing of its product.

FDA tracking MS drug's link to brain infection

There is no telling yet whether a certain multiple sclerosis drug actually causes a brain infection; nevertheless, the U.S. Food and Drug Administration announced Aug. 4 the emergence of a couple of cases that apparently raised suspicions. We will simply have to wait and see the outcome of further FDA investigations.

FDA tracking MS drug's link to brain infection

There is no telling yet whether a certain multiple sclerosis drug actually causes a brain infection; nevertheless, the U.S. Food and Drug Administration announced Aug. 4 the emergence of a couple of cases that apparently raised suspicions. We will simply have to wait and see the outcome of further FDA investigations.

FDA issues new 'scope' superbug prevention procedures

The use of the duodenoscope, which is used to examine a part of the small intestine, has been linked to the outbreak of drug-resistant so-called "superbugs" at hospitals in Los Angeles and elsewhere in the U.S. While some of the victims have filed product liability lawsuits against one of the device's leading manufacturers, the U.S. Food and Drug Administration has issued a new list of measures intended to clean the device between uses.

FDA issues new 'scope' superbug prevention procedures

The use of the duodenoscope, which is used to examine a part of the small intestine, has been linked to the outbreak of drug-resistant so-called "superbugs" at hospitals in Los Angeles and elsewhere in the U.S. While some of the victims have filed product liability lawsuits against one of the device's leading manufacturers, the U.S. Food and Drug Administration has issued a new list of measures intended to clean the device between uses.

Studies published on SSRI antidepressants and birth defects

A pair of respected medical journals published studies within the last couple of months that linked the expectant mother's use of selective serotonin reuptake inhibitor antidepressants with certain birth defects. The findings were released while SSRI antidepressant lawsuits have been filed against the makers of some of these popular drugs. Plaintiffs alleged the birth defects connection.

Studies published on SSRI antidepressants and birth defects

A pair of respected medical journals published studies within the last couple of months that linked the expectant mother's use of selective serotonin reuptake inhibitor antidepressants with certain birth defects. The findings were released while SSRI antidepressant lawsuits have been filed against the makers of some of these popular drugs. Plaintiffs alleged the birth defects connection.

Email Us For A Response

Contact Us For a Free Legal Consultation There is a never a fee unless we recover on your behalf.

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Call for a Free Legal Consultation: 713-352-7883
Reich & Binstock - Pharmaceutical Injury & Class Action Lawyers

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Houston Law Office Map